Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 8:57 pm Purchase |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 3,410,412 13.200% |
3,410,412 (New Position) |
Filing History |
| 2021-02-16 4:00 pm Purchase |
2020-12-31 | 13G | Neptune Wellness Solutions Inc. NEPT |
PERCEPTIVE ADVISORS LLC | 15,868 17.200% |
2,698 (+20.49%) |
Filing History |
| 2021-02-16 3:57 pm Sale |
2020-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
PERCEPTIVE ADVISORS LLC | 2,577,043 4.300% |
-676,880 (-20.80%) |
Filing History |
| 2021-02-16 3:54 pm Purchase |
2020-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
PERCEPTIVE ADVISORS LLC | 7,960 18.200% |
2,000 (+33.56%) |
Filing History |
| 2021-02-16 3:50 pm Purchase |
2020-12-31 | 13G | Kadmon Holdings, Inc. KDMN |
PERCEPTIVE ADVISORS LLC | 16,240,747 9.400% |
1,075,000 (+7.09%) |
Filing History |
| 2021-02-16 3:50 pm Purchase |
2020-12-31 | 13G | SC Health Corporation SCPE |
PERCEPTIVE ADVISORS LLC | 1,000,000 5.800% |
1,000,000 (New Position) |
Filing History |
| 2021-02-16 3:48 pm Purchase |
2020-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
PERCEPTIVE ADVISORS LLC | 3,158,566 7.300% |
3,158,566 (New Position) |
Filing History |
| 2021-02-16 3:47 pm Sale |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-3,410,412 (Position Closed) |
Filing History |
| 2021-02-16 3:46 pm Purchase |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
PERCEPTIVE ADVISORS LLC | 1,296,416 6.400% |
1,296,416 (New Position) |
Filing History |
| 2021-02-16 3:46 pm Purchase |
2020-12-31 | 13G | Oncorus, Inc. ONCR |
PERCEPTIVE ADVISORS LLC | 1,989,987 7.700% |
1,989,987 (New Position) |
Filing History |
| 2021-02-16 3:46 pm Purchase |
2020-12-31 | 13G | Outset Medical, Inc. OM |
PERCEPTIVE ADVISORS LLC | 189,855 6.700% |
189,855 (New Position) |
Filing History |
| 2021-02-16 3:45 pm Purchase |
2020-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
PERCEPTIVE ADVISORS LLC | 3,396,867 5.600% |
3,396,867 (New Position) |
Filing History |
| 2021-02-16 3:45 pm Purchase |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
PERCEPTIVE ADVISORS LLC | 1,500,000 10.700% |
1,500,000 (New Position) |
Filing History |
| 2021-02-16 3:44 pm Unchanged |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:42 pm Purchase |
2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 847,650 14.200% |
175,000 (+26.02%) |
Filing History |
| 2021-02-16 3:41 pm Sale |
2020-12-31 | 13G | Molecular Templates, Inc. MTEM |
PERCEPTIVE ADVISORS LLC | 40,121 1.200% |
-170,821 (-80.98%) |
Filing History |
| 2021-02-16 3:40 pm Purchase |
2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
PERCEPTIVE ADVISORS LLC | 2,058,068 6.000% |
336,346 (+19.54%) |
Filing History |
| 2021-02-16 3:39 pm Purchase |
2020-12-31 | 13G | VYNE Therapeutics Inc. VYNE |
PERCEPTIVE ADVISORS LLC | 1,505,323 14.300% |
1,505,323 (New Position) |
Filing History |
| 2021-02-16 3:38 pm Sale |
2020-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-1,141,484 (Position Closed) |
Filing History |
| 2021-02-16 3:38 pm Sale |
2020-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
PERCEPTIVE ADVISORS LLC | 1,385,720 4.100% |
-864,280 (-38.41%) |
Filing History |